Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
293 Leser
Artikel bewerten:
(1)

MEDHOST Announces General Availability of Enterprise and EDIS 2024 R1 Releases: Advancing Healthcare Interoperability

FRANKLIN, TENNESSEE / ACCESS Newswire / November 17, 2025 / MEDHOST, a leading EHR and healthcare IT solutions provider, has announced the general availability of its Enterprise 2024 R1 and EDIS 2024 R1 releases, along with the MEDHOST Health Data, Technology, and Interoperability - 1 (HTI-1) Solution. Together, these offerings form a comprehensive suite of integrated solutions designed to advance interoperability, compliance, and workflow optimization across healthcare enterprises and emergency departments.

Nurse on computer

Nurse on computer
Nurse on computer

MEDHOST Enterprise 2024 R1

Empowering Clinical and Financial Operations

The Enterprise 2024 R1 release introduces advanced capabilities to help healthcare organizations streamline clinical documentation, improve operational efficiency, and prepare for evolving interoperability requirements.

With this update, MEDHOST customers can also leverage the HTI-1 Solution, designed to support compliance with new rules by supporting leading healthcare data standards such as FHIR and HL7 to ensure consistent and secure data exchange, and expand data exchange capabilities.

Key Enhancements Include:

  • Enhanced charting capabilities streamlining notes with new filters, and improving patient health concerns documentation

  • Optimized pharmacy workflows, including medication credits and real-time refresh

  • Improved Patient Access registration documentation

MEDHOST HTI-1 Solution

Advancing Interoperability and Compliance

The MEDHOST HTI-1 Solution enables providers to align with regulatory standards, improve patient data accuracy, and expand safety measures. Key Features:

  • Enhances patient demographics, including preferred names and pronouns

  • Expands patient safety measures with additional emergency contact capacity

  • Leverages greater capabilities such as USCDI v3 compliance, advanced APIs, and enhanced decision support

For additional insights into HTI-1 compliance and its impact on healthcare interoperability, MEDHOST invites readers to download the HTI-1 eBook available on the company's website.

MEDHOST EDIS 2024 R1

Driving Emergency Department Efficiency and Patient Care

The EDIS 2024 R1 release delivers focused enhancements for emergency departments, supporting faster, more intuitive workflows and improved data exchange through HTI-1 compliance.

Highlights Include:

  • Streamlined Workflows: Simplified navigation and optimized interface responsiveness to support faster, more intuitive emergency department operations.

  • Advanced Reporting: Expanded customization options and data insights for more meaningful, actionable reporting.

  • Improved Usability: Refinements across core modules make critical information easier to access, helping clinicians work efficiently and reducing onboarding time.

  • Enhanced Interoperability: Supports upgrades to the United States Core Data for Interoperability (USCDI) v3 standard for EDIS specific workflow components, ensuring better data sharing and compliance.

Commitment to Ongoing Innovation

"MEDHOST Enterprise 2024 R1 and our HTI-1 Solution reflect an ongoing commitment to innovation and compliance," said Stephanie Sames, Executive Vice President at MEDHOST. "This release not only streamlines workflows for providers but also prepares them for the future of healthcare interoperability and regulatory readiness, including compliance with the latest ONC final rule for health IT and interoperability."

Customers are encouraged to schedule their upgrades to benefit from the latest performance improvements, reporting capabilities, and regulatory readiness.

For more information, visit www.medhost.com.

Contact Information

Kenyatta Owens
Senior Director, Marketing
media@medhost.com
1.800.383.6278

.

SOURCE: MEDHOST



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/medhost-announces-general-availability-of-enterprise-and-edis-2024-r1-1103320

© 2025 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.